Working… Menu

A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00809796
Recruitment Status : Completed
First Posted : December 17, 2008
Last Update Posted : June 28, 2011
Information provided by:
Oncozyme Pharma Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2011
Actual Study Completion Date : June 2011